854010-13-2

Basic information

• Product Name: Furo[3,4-c]pyridin-7-ol, 1,3-dihydro-1-(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-6-methyl-
• CAS NO: 854010-13-2
• Molecular Formula: C18H17N3O3
• Molecular Weight: 323.351
• Mol File: 854010-13-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Furo[3,4-c]pyridin-7-ol, 1,3-dihydro-1-(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-6-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Furo[3,4-c]pyridin-7-ol, 1,3-dihydro-1-(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-6-methyl-(854010-13-2)
• EPA Substance Registry System: Furo[3,4-c]pyridin-7-ol, 1,3-dihydro-1-(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-6-methyl-(854010-13-2)

Safety Data

• Hazardous Substances Data: 854010-13-2(Hazardous Substances Data)

Upstream product

• 65-22-5 pyridoxal hydrochloride 
• 89-25-8 edaravone 

Relevant articles and documents

Preparing method for pyrazole compound

The invention discloses a preparing method for a pyrazole compound. The preparing method for the pyrazole compound is a method (1) or a method (2), wherein the method (1) includes the steps that a water solution of alkali is added into a water solution of

Detection and Treatment of Schizophrenia

The present invention provides a method for diagnosing schizophrenia, and a schizophrenia diagnostic reagent or device for use in the method. The present invention further provides a therapeutic or ameliorating agent for schizophrenia, which is effective for the treatment or amelioration of schizophrenia. The therapeutic or ameliorating agent for schizophrenia contains a carbonyl scavenger or a carbonyl-modified protein formation inhibitor as an active ingredient. The method for diagnosing schizophrenia according to the present invention includes measuring at least one parameter in a subject, the parameter being selected from the group consisting of: (1) a genetic abnormality of glyoxalase I gene; (2) the expression level or activity of glyoxalase I in a biological sample; (3) the amount of a carbonyl compound or a carbonyl-modified protein that is a protein modified with the carbonyl compound; and (4) the amount of pyridoxal in a biological sample.